X0306 4 2016-06-10 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 President and CEO Common Stock 2016-06-10 4 M 0 11326 2.63 A 650396 D Common Stock 2016-06-10 4 S 0 11326 3.0709 D 639070 D Common Stock 2016-06-10 4 M 0 81990 2.50 A 5317452 I See footnote Common Stock 2016-06-10 4 M 0 10050 2.63 A 5327502 I See footnote Common Stock 2016-06-10 4 S 0 92040 3.0547 D 5235462 I See footnote Common Stock 2016-06-13 4 M 0 128674 2.63 A 767744 D Common Stock 2016-06-13 4 S 0 128674 3.0247 D 639070 D Common Stock 2016-06-13 4 M 0 139950 2.63 A 5375412 I See footnote Common Stock 2016-06-13 4 S 0 139950 3.0198 D 5235462 I See footnote Stock Option (right to buy) 2.63 2016-06-10 4 M 0 11326 0 D 2016-06-14 Common Stock, par value $0.01 per share 11326 128674 D Stock Option (right to buy) 2.50 2016-06-10 4 M 0 81990 0 D 2016-06-10 Common Stock, par value $0.01 per share 81990 0 I See footnote Stock Option (right to buy) 2.63 2016-06-10 4 M 0 10050 0 D 2016-06-14 Common Stock, par value $0.01 per share 10050 139950 I See footnote Stock Option (right to buy) 2.63 2016-06-13 4 M 0 128674 0 D 2016-06-14 Common Stock, par value $0.01 per share 128674 0 D Stock Option (right to buy) 2.63 2016-06-13 4 M 0 139950 0 D 2016-06-14 Common Stock, par value $0.01 per share 139950 0 I See footnote Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Patent Officer and Chairman of the Board of Directors. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.07 to $3.08. The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.04 to $3.085. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $3.00 to $3.12. The price in column 4 is a weighted average price. The prices actually received in this transaction range from $2.96 to $3.12. These stock options were granted pursuant to the Issuer's 2002 Stock Option Plan, and vested over four years at a rate of 25% per year. These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan. The reporting person's spouse was granted these stock options pursuant to the Issuer's 2002 Stock Incentive Plan. /s/ Cynthia L. Goldenberg 2016-06-14